Atom Investors’s Niagen Bioscience NAGE Stock Holding History

Atom Investors’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-14,641	Closed	-$137K	–	858
2025 Q3	$137K	Buy	+14,641	New	+$148K	0.01%	537

Other funds holding NAGE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Atom Investors's NAGE Position: Q4 2025 in Review

Atom Investors sold out of Niagen Bioscience (NAGE) in Q4 2025, closing a stake of 14,641 shares — an estimated $137K sold.

Atom Investors first reported a position in NAGE in Q3 2025 and held it in 1 quarter. The position peaked at $137K in Q3 2025. 169 funds tracked by Wall St. Rank hold NAGE as of Q4 2025.

Atom Investors reported no remaining Niagen Bioscience position as of Q4 2025 after selling out during the quarter.
Atom Investors sold 14,641 Niagen Bioscience shares in Q4 2025, an estimated $137K.
Atom Investors first reported a position in Niagen Bioscience in Q3 2025 and held it in 1 quarter.
Atom Investors's Niagen Bioscience position peaked at $137K in Q3 2025.
169 funds tracked by Wall St. Rank held Niagen Bioscience as of Q4 2025.

Based on Atom Investors's 13F filing for Q4 2025, filed 17 Feb 2026.